PROVISION OF TUMOUR PROFILING TEST
A Contract Award Notice
by NHS SOUTH WEST - ACUTES
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- not specified
- Value
- £122K
- Sector
- HEALTH
- Published
- 26 Apr 2022
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
TORBAY HOSPITAL
2 buyers
- NHS South West Acutes Torquay
1 supplier
- Exact Sciences London
Description
Nice guidelines recommend Endopredict, Oncotype DX or Prosigna Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer. Of these 3 tests it has been confirmed that Oncotype DX is the only one available under the framework, Contract Ref. Pathology and Point of Care Testing, Associated Equipment, Instruments, Consumables and Accessories and Managed Services (2019/S 212-519575). A direct award has been made to Exact Sciences for Oncotype DX for the following reason: Specialist expertise is required and only available from one source.
Total Quantity or Scope
Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer.
Award Detail
1 | Exact Sciences (London)
|
Award Criteria
NICE GUIDELINES | 50.0 |
PRICE | 50.0 |
CPV Codes
- 33124130 - Diagnostic supplies
Indicators
- Award on basis of price.
Legal Justification
Nice guidelines recommend Endopredict, Oncotype DX or Prosigna Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer. Of these 3 tests it has been confirmed that Oncotype DX is the only one available under the framework, Contract Ref. Pathology and Point of Care Testing, Associated Equipment, Instruments, Consumables and Accessories and Managed Services (2019/S 212-519575). A direct award has been made to Exact Sciences for Oncotype DX for the following reason: Specialist expertise is required and only available from one source.
Reference
- FTS 010759-2022